JHS Svendgaard Laboratories Limited

JHS Svendgaard Labs: AGM on Sep 26, 2026, Adopts FY26 Financials, Appoints Director

JHS Svendgaard Laboratories Limited's 22nd AGM on Sep 26, 2026, adopted FY26 standalone and consolidated financial statements. Mr. Paramvir Singh was appointed as director. All resolutions passed with overwhelming majority.

JHS Svendgaard Holds 22nd AGM on Sep 26, 2026, Discusses FY26 Results

JHS Svendgaard Laboratories Limited held its 22nd AGM on September 26, 2026. The meeting included the adoption of audited standalone and consolidated financial statements for FY26 and the appointment of Mr. Paramvir Singh as a director. The company discussed its performance and future outlook.

JHS Svendgaard Laboratories: Trading Window Closed for Q2FY27 Results

JHS Svendgaard Laboratories will close its trading window from October 1, 2026, until 48 hours after the declaration of Q2FY27 financial results. This is in accordance with SEBI insider trading regulations.

JHS Svendgaard to hold 22nd AGM on Sep 26, 2026, for FY25-26 Annual Report

JHS Svendgaard Laboratories Limited will hold its 22nd AGM on September 26, 2026, to discuss the FY25-26 Annual Report. E-voting is open from September 23 to September 25, 2026. Shareholders are reminded to update KYC details.

JHS Svendgaard Announces 22nd AGM on September 26, 2026

JHS Svendgaard Laboratories Limited will hold its 22nd Annual General Meeting on September 26, 2026, via video conference. Remote e-voting will be open from September 23 to September 25, 2026. The cut-off date for eligibility is September 19, 2026. The AGM notice and annual report are available online.

JHS Svendgaard Laboratories to hold 22nd AGM on Sep 26, 2026

JHS Svendgaard Laboratories Limited will conduct its 22nd Annual General Meeting on September 26, 2026. The AGM will focus on adopting the audited standalone and consolidated financial statements for FY26 and re-appointing Mr. Paramvir Singh as a director. E-voting is available from September 23-25, 2026.

JHS Svendgaard Laboratories Limited announces 22nd AGM on Sep 26, 2026

JHS Svendgaard Laboratories Limited will hold its 22nd AGM on September 26, 2026, at 3:00 PM via VC/OAVM. The Annual Report for FY26 and AGM notice will be sent electronically to registered members by August 28, 2026.

JHS Svendgaard Laboratories Ltd. Publishes Q1 FY27 Financial Results

JHS Svendgaard Laboratories Limited reported Q1 FY27 results. Total income from operations was ₹30.38 crore. Net profit after tax was ₹1.09 crore on a consolidated and standalone basis. Results approved on August 11, 2026.

JHS Svendgaard Labs Q1 FY27 Results: Net Profit ₹1.09 Crore

JHS Svendgaard Laboratories reported a net profit of ₹1.09 crore for the quarter ended June 30, 2026. This marks a significant improvement from a net loss of ₹3.57 crore in the corresponding quarter of the previous year. Total income for the quarter was ₹30.47 crore.

JHS Svendgaard shareholders approve fund utilization modification via postal ballot.

JHS Svendgaard shareholders approved a modification in fund utilization from a preferential issue via postal ballot. The resolution passed on July 29th, 2026, with over 99.93% of votes in favor.

JHS Svendgaard Labs: Postal Ballot Voting Concludes July 29, 2026

JHS Svendgaard Laboratories Limited concluded its postal ballot by remote e-voting on July 29, 2026. The vote sought approval for modifying the utilization of funds from a preferential issue of equity shares and warrants. The Scrutinizer's report is awaited.

JHS Svendgaard Labs Files Certificate Under SEBI Depositories Regulations

JHS Svendgaard Laboratories Limited submitted a certificate for the quarter ended June 30, 2026, under SEBI (Depositories and Participants) Regulations, 2018. The company's RTA confirmed dematerialization processing and cancellation of old certificates.

JHS Svendgaard Laboratories Announces Postal Ballot Notice Publication

JHS Svendgaard Laboratories published a newspaper advertisement on June 30, 2026, for a Notice of Postal Ballot dated June 29, 2026. E-voting runs from June 30 to July 29, 2026. A scrutinizer has been appointed.

JHS Svendgaard Laboratories seeks approval for fund utilization modification via postal ballot

JHS Svendgaard Laboratories is conducting a postal ballot to modify the utilization of ₹29.99 crore raised via preferential issue. The e-voting period is from June 30, 2026, to July 29, 2026. The proposed changes aim to provide flexibility in funding capital expenditure, business expansion, and strategic initiatives, with a revised utilization timeline by March 31, 2027.

JHS Svendgaard Laboratories Limited: Newspaper Publication of Financial Results for Q4FY26

JHS Svendgaard Laboratories Limited published its financial results for the quarter and year ended March 31, 2026. The results were advertised in Business Standard on May 28, 2026, and are available on the company's website.

JHS Svendgaard Labs Approves Audited FY26 Financial Results

JHS Svendgaard Laboratories Limited's Board approved the audited financial results for the quarter and year ended March 31, 2026. The results were recommended by the Audit Committee and received an unmodified auditor's report. The meeting took place on May 26, 2026.

JHS Svendgaard Laboratories Files Revised Financial Results for Q2 FY26

JHS Svendgaard Laboratories Limited has filed revised Integrated Financial Results for the quarter ended September 2025. The company corrected inaccuracies in the Board Meeting end time and EPS figures, which were initially reported incorrectly. The revised results were submitted on April 29, 2026.

JHS Svendgaard Appoints Beetal Financial as New RTA

JHS Svendgaard Laboratories Limited has changed its Registrar and Share Transfer Agent (RTA) to Beetal Financial & Computer Services (P) Limited. The change was formalized via a Tripartite Agreement on April 27, 2026, effective immediately. This move aims to enhance investor services.

JHS Svendgaard Laboratories: Certificate under SEBI Reg. 74(5) for Q4FY26

JHS Svendgaard Laboratories Limited submitted a certificate for Q4FY26 under SEBI Regulation 74(5). The Registrar and Share Transfer Agent confirmed dematerialization processing for shares received between Feb 24 and Mar 31, 2026. Certificates were cancelled and depositories updated as registered owners.

JHS Svendgaard Appoints Beetal Financial as New Registrar & Share Transfer Agent

JHS Svendgaard Laboratories Limited is changing its Registrar and Share Transfer Agent (RTA) from Alankit Assignments Limited to Beetal Financial and Computer Services (P) Ltd. This move aims to enhance investor services. A tripartite agreement is in process, and the effective date will be announced later.

JHS Svendgaard Labs Publishes Investor Education Notice

JHS Svendgaard Laboratories Limited published a notice on April 13, 2026, supporting the IEPF Authority's "Saksham Niveshak" campaign. The campaign encourages shareholders to update KYC details and claim unpaid dividends to prevent transfer to IEPF.

JHS Svendgaard Publishes Notice on Special Window for Physical Share Transfers

JHS Svendgaard Laboratories Limited announced a special window for re-lodging physical share transfer requests. The window runs from February 5, 2026, to February 4, 2027, for deeds lodged before April 1, 2019, or previously rejected requests. Details are available on the company website.

JHS Svendgaard clarifies financial results discrepancy for Q3 FY26

JHS Svendgaard clarifies financial results discrepancy for the quarter ended December 31, 2025. The Board approved the results on February 10, 2026, authorizing a director to sign them. The company confirms compliance with SEBI regulations.

JHS Svendgaard Laboratories: Trading Window Closed for Q4FY26 Results

JHS Svendgaard Laboratories Limited will close its trading window from April 1, 2026. This is in compliance with SEBI regulations and the company's insider trading code. The window will reopen 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026.

JHS Svendgaard Laboratories Q3FY26 Financial Results Published

JHS Svendgaard Laboratories reported Q3FY26 results. Standalone profit after tax was ₹789 lacs for the quarter and ₹164.83 lacs for nine months. Consolidated profit after tax was ₹768.9 lacs for the quarter and ₹164.63 lacs for nine months.

JHS Svendgaard Appoints A.R. & Co. as Internal Auditor for 3 Years

JHS Svendgaard Laboratories Limited has appointed M/s A.R. & Co., Chartered Accountants, as its Internal Auditor for a three-year term from FY 2025-26 to FY 2027-28. The appointment was approved by the Board on February 10, 2026.

JHS Svendgaard Labs Q3 FY26: Net Profit ₹0.79 Lakhs (Standalone)

JHS Svendgaard Laboratories reported standalone net profit of ₹0.79 lakh for Q3 FY26, a turnaround from a loss last year. Consolidated net profit was ₹78.89 lakh. Revenue from operations stood at ₹23.85 crore (consolidated). The company also approved conversion of warrants into equity shares.

JHS Svendgaard Grants 2.5 Lakh Stock Options Under 2025 Scheme

JHS Svendgaard Laboratories granted 2,50,000 Employee Stock Options under its 2025 Scheme on February 10, 2026. Each option is convertible into one equity share of face value Rs. 10. The exercise price is set at Rs. 10 per option. Vesting begins one year after the grant date.

JHS Svendgaard Grants 2.5 Lakh Employee Stock Options

JHS Svendgaard Laboratories Limited granted 2,50,000 employee stock options on February 10, 2026. Each option is convertible into one equity share of face value ₹10, with an exercise price of ₹10. The options are part of the company's 2025 Employee Stock Option Scheme.

JHS Svendgaard Allots 18.01 Lakh Shares Post Warrant Conversion

JHS Svendgaard approved the allotment of 18,01,801 equity shares following the conversion of warrants. This conversion, involving Coeus Global Opportunities Fund, resulted in an inflow of ₹3.75 crore. The company's paid-up share capital increased to ₹87.41 crore.

JHS Svendgaard Labs Files Certificate Under SEBI Depositories Regulations

JHS Svendgaard Laboratories Limited submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018. The certificate for the quarter ending December 31, 2025, confirms the dematerialization of physical share certificates received by the registrar and transfer agent, Alankit Assignments Limited.

JHS Svendgaard Laboratories: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

JHS Svendgaard Laboratories will close its trading window from January 1, 2026. The closure is for insiders and their relatives and will last until 48 hours after the declaration of financial results for the quarter and nine months ended December 31, 2025. The date of the board meeting for results will be announced later.

JHS Svendgaard Labs Publishes Notice for Special Window for Physical Share Transfers

JHS Svendgaard Laboratories Limited has opened a special window for re-lodging physical share transfer requests from July 7, 2025, to January 6, 2026. This is to address transfers lodged before April 1, 2019, that were returned due to documentation issues.

JHS Svendgaard Laboratories Announces Financial Results Publication

JHS Svendgaard Laboratories Limited announced the publication of its financial results for the quarter and half-year ended September 30, 2025, in Financial Express and Jansatta on November 16, 2025.

JHS Svendgaard Board Approves Q2 FY26 Un-Audited Financial Results; Reports Quarterly Loss, Half-Yearly Profit

JHS Svendgaard's Board approved Q2 FY26 financial results. The company reported a net loss for the quarter but a significant profit turnaround for the half-year, with ongoing strategic fund utilization.

Grant of 31,30,000 Employee Stock Options under ESOP Scheme 2025

JHS Svendgaard Laboratories grants 31,30,000 employee stock options under ESOP Scheme 2025, convertible into equity shares of ₹10 each, with an exercise price of ₹10 per option.

JHS Svendgaard Laboratories Receives Warning Letter from NSE and BSE

JHS Svendgaard Laboratories received a warning from NSE and BSE for non-compliance with SEBI LODR regarding the absence of the Stakeholders Relationship Committee Chairperson at the AGM.

Certificate under SEBI (Depositories and Participants) Regulations, 2018

JHS Svendgaard Laboratories Limited submits a certificate under SEBI regulations regarding dematerialization of securities for the quarter ending September 30, 2025.

JHS Svendgaard Labs Clarifies Financial Results for Quarter Ended June 30, 2025

JHS Svendgaard Labs clarifies financial results for Q1 2025-26, addressing authorization and XBRL discrepancies, and confirming board approval of unaudited results.

JHS Svendgaard Shareholders Approve 40 Lakh Employee Stock Option Scheme 2025

JHS Svendgaard appoints Nikhil Nanda as Managing Director for 5 years

JHS Svendgaard Labs Appoints Statutory and Secretarial Auditors

JHS Svendgaard Laboratories Holds 21st Annual General Meeting on September 20, 2025

JHS Svendgaard Launches 'Saksham Niveshak' Campaign for Unclaimed Dividends

JHS Svendgaard Laboratories Announces 21st AGM on September 20, 2025, Dispatches Annual Report

JHS Svendgaard to hold 21st AGM on September 20, 2025

JHS Svendgaard Laboratories approves Employee Stock Option Scheme 2025